288 related articles for article (PubMed ID: 20857187)
1. Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.
Meade CS; Conn NA; Skalski LM; Safren SA
J Behav Med; 2011 Apr; 34(2):128-38. PubMed ID: 20857187
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
[TBL] [Abstract][Full Text] [Related]
3. Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence.
Anderson AM; Higgins MK; Ownby RL; Waldrop-Valverde D
AIDS Care; 2015; 27(3):333-7. PubMed ID: 25484035
[TBL] [Abstract][Full Text] [Related]
4. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
[TBL] [Abstract][Full Text] [Related]
5. Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States.
Meade CS; Towe SL; Skalski LM; Robertson KR
Drug Alcohol Depend; 2015 Apr; 149():128-35. PubMed ID: 25697913
[TBL] [Abstract][Full Text] [Related]
6. Aging, neurocognition, and medication adherence in HIV infection.
Ettenhofer ML; Hinkin CH; Castellon SA; Durvasula R; Ullman J; Lam M; Myers H; Wright MJ; Foley J
Am J Geriatr Psychiatry; 2009 Apr; 17(4):281-90. PubMed ID: 19307857
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.
Hinkin CH; Hardy DJ; Mason KI; Castellon SA; Durvasula RS; Lam MN; Stefaniak M
AIDS; 2004 Jan; 18 Suppl 1(Suppl 1):S19-25. PubMed ID: 15075494
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive impairment and HIV risk factors: a reciprocal relationship.
Anand P; Springer SA; Copenhaver MM; Altice FL
AIDS Behav; 2010 Dec; 14(6):1213-26. PubMed ID: 20232242
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal change in cognitive function and medication adherence in HIV-infected adults.
Becker BW; Thames AD; Woo E; Castellon SA; Hinkin CH
AIDS Behav; 2011 Nov; 15(8):1888-94. PubMed ID: 21437726
[TBL] [Abstract][Full Text] [Related]
10. Cocaine Use May Moderate the Associations of HIV and Female Sex with Neurocognitive Impairment in a Predominantly African American Population Disproportionately Impacted by HIV and Substance Use.
Lai H; Celentano DD; Treisman G; Khalsa J; Gerstenblith G; Page B; Mandler RN; Yang Y; Salmeron B; Bhatia S; Chen S; Lai S; Goodkin K; Charurat M
AIDS Patient Care STDS; 2023 May; 37(5):243-252. PubMed ID: 37083446
[TBL] [Abstract][Full Text] [Related]
11. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users.
Ingersoll KS; Farrell-Carnahan L; Cohen-Filipic J; Heckman CJ; Ceperich SD; Hettema J; Marzani-Nissen G
Drug Alcohol Depend; 2011 Jul; 116(1-3):177-87. PubMed ID: 21306837
[TBL] [Abstract][Full Text] [Related]
12. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive intra-individual variability within HIV+ adults with and without current substance use.
Arce RenterĂa M; Byrd D; Coulehan K; Miranda C; Fuentes A; Rosario AK; Morris EP; Rivera Mindt M
Neuropsychology; 2020 Mar; 34(3):321-330. PubMed ID: 31886690
[TBL] [Abstract][Full Text] [Related]
14. The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users.
Waldrop-Valverde D; Jones DL; Weiss S; Kumar M; Metsch L
AIDS Care; 2008 Nov; 20(10):1202-10. PubMed ID: 19012081
[TBL] [Abstract][Full Text] [Related]
15. The Combined Roles of Nonsomatic Depressive Symptomatology, Neurocognitive Function, and Current Substance Use in Medication Adherence in Adults Living With HIV Infection.
Scott TM; Byrd D; Arce RenterĂa M; Coulehan K; Miranda C; Fuentes A; Rivera Mindt M
J Assoc Nurses AIDS Care; 2018; 29(2):178-189. PubMed ID: 28988793
[TBL] [Abstract][Full Text] [Related]
16. Medication-taking self-efficacy and medication adherence among HIV-infected cocaine users.
Waldrop-Valverde D; Dong C; Ownby RL
J Assoc Nurses AIDS Care; 2013; 24(3):198-206. PubMed ID: 23122904
[TBL] [Abstract][Full Text] [Related]
17. Baseline Substance Use Interferes with Maintenance of HIV Medication Adherence Skills.
Dale SK; Traeger L; O'Cleirigh C; Bedoya CA; Pinkston M; Wilner JG; Stein M; Safren SA
AIDS Patient Care STDS; 2016 May; 30(5):215-20. PubMed ID: 27158849
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive aspects of medication adherence in HIV infection.
Selnes OA
J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S132-5. PubMed ID: 12562036
[TBL] [Abstract][Full Text] [Related]
19. Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.
Patton DE; Woods SP; Franklin D; Cattie JE; Heaton RK; Collier AC; Marra C; Clifford D; Gelman B; McArthur J; Morgello S; Simpson D; McCutchan JA; Grant I
AIDS Behav; 2012 Nov; 16(8):2286-96. PubMed ID: 22722882
[TBL] [Abstract][Full Text] [Related]
20. Psycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana.
Asiedu N; Kretchy I; Asampong E
Afr Health Sci; 2020 Jun; 20(2):487-596. PubMed ID: 33163015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]